Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles

References

Page 1

	Year	Citations
Anticancer potential of curcumin: preclinical and clinical studies. Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti PubMed Chemoprevention StrategyMedicinePharmacologyAnticancer PotentialPathology	2003	2.6K
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin, PubMed Urinary Bladder CancerChemopreventive AgentOncologyChemoprevention StrategyOncogenic Agent	2001	2.1K
Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells Srinivas Ganta, Mansoor M. Amiji Molecular Pharmaceutics	2009	487
Targeted nanoparticles for cancer therapy Frank Gu, Rohit Karnik, Andrew Z. Wang, Nano Today NanoparticlesNanomedicineCancer TherapyEngineeringTherapeutic Nanomaterials	2007	466
Targeted Nanoparticles for Cancer Therapy Gundlapally Sathyanarayana Reddy Journal of Bioanalysis & Biomedicine NanoparticlesNanomedicineCancer TherapyEngineeringTherapeutic Nanomaterials	2021	401
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression Monica Notarbartolo, Paola Poma, Daniela Perri, Cancer Letters Iap Gene ExpressionOncogenic AgentMedicinePharmacologyPathology	2005	318
Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP Xiaowei Dong, Cynthia A. Mattingly, Michael T. Tseng, Cancer Research NanomedicinePaclitaxel NanoparticlesHealth SciencesBiochemistryPolymer-drug Conjugate	2009	283
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles Claire Emilienne Soma, Catherine Dubernet, Dvora Bentolila, Biomaterials Polyalkylcyanoacrylate NanoparticlesEngineeringPolymer-drug ConjugatePolymer ScienceMultidrug Resistance	2000	280
Degradation of poly (isobutyl cyanoacrylate) nanoparticles Vincent Lenaerts, Patrick Couvreur, Dominique Christiaens-Leyh, Biomaterials Materials ScienceEngineeringNanomaterialsPolymer SciencePlastic Degradation	1984	268
Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles Xiang Song, Zheng Cai, Yu Zheng, European Journal of Pharmaceutical Sciences NanomedicineMedicinal ChemistryEngineeringPolymer-drug ConjugatePharmaceutical Nanotechnology	2009	211

Page 1